US 11219614
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
granted A61KA61K31/198A61K31/375
Quick answer
US patent 11219614 (Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound) held by Galera Labs, LLC expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Galera Labs, LLC
- Grant date
- Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/198, A61K31/375, A61K31/555, A61K31/635